本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ProQR Therapeutics N.V.

1.57
-0.2300-12.78%
成交量:36.06萬
成交額:59.13萬
市值:1.65億
市盈率:-4.70
高:1.79
開:1.75
低:1.57
收:1.80
資料載入中...
2025/03/22

SEC問詢函

Form CORRESP - Correspondence
2025/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/10/08

SEC問詢函

Form CORRESP - Correspondence
2024/03/13

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/20

SEC問詢函

Form CORRESP - Correspondence
2023/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/07

SEC問詢函

CORRESP [Cover] - Correspondence
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals